Analysis of Clinical Factors, Bacterial Genotyping, and Drug Resistance for Spinal Tuberculosis in South-Central China

Table 4

Analysis of different MTB genotypes resistance to different ATDs (resistance rate: %).

Drug species	Beijing type		Nonbeijing type		All strains
	Drug-resistant strains	Resistance rate	Drug-resistant strains	Resistance rate	Drug-resistant strains	Resistance rate
INH	17	62.96	4	14.81	21	37.5
RFP	16	59.26	3	11.11	19	33.93
SM	13	48.15	2	6.89	15	26.79
EMB	9	33.33	2	6.89	11	19.64
CPM-SO4	3	11.11	1	3.70	4	7.14
CPFX	5	18.52	2	6.89	7	12.50
OFLX	4	14.81	0	0	4	7.14
PTH	1	3.70	0	0	1	1.79
INH + RFP + SM	10	37.04	2	6.89	12	21.43
INH + RFP + SM  + EMB	8	29.63	0	0	8	14.29
MDR	15	55.56	2	6.89	17	30.36
XDR	4	14.81	0	0	4	7.14

Independent sample T test of drug resistance to different ATDs between Beijing and nonBeijing types, .